AHL
RCEL icon

Abel Hall LLC’s Avita Medical RCEL Stock Holding History

Abel Hall LLC’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.2K Sell
15,779
-1,031
-6% -$4.45K 0.01% 878
2026
Q1 		$62.2K Buy
+16,810
New +$70.6K 0.01% 726

Other funds holding RCEL

TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Abel Hall LLC's RCEL Position: Q2 2026 in Review

Abel Hall LLC reduced its Avita Medical (RCEL) stake by 6.1% in Q2 2026, selling an estimated $4.45K and leaving 15,779 shares worth $65.2K. The position accounts for 0.01% of the portfolio, ranked #878.

Abel Hall LLC first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Abel Hall LLC held 15,779 shares of Avita Medical worth $65.2K as of Q2 2026.
  • Abel Hall LLC sold 1,031 Avita Medical shares in Q2 2026, an estimated $4.45K.
  • Avita Medical made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #878 holding.
  • Abel Hall LLC first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.